ANO1 and neoplasm: The excellent internalization efficiency of the anti-DOG1 antibody and the feature of widely expression of DOG1 in many tumors, make DOG1 a great potential to be an ADC drug which, theoretically, could be a broad-spectrum anti-tumor drug against DOG1 positive cancer.